Literature DB >> 11988652

Effects of lactated Ringer's solutions on human leukocytes.

Elena Koustova1, Kathleen Stanton, Vadim Gushchin, Hasan B Alam, Svetlana Stegalkina, Peter M Rhee.   

Abstract

BACKGROUND: The standard lactated Ringer's (LR) solution contains racemic lactate, an equal mixture of D(-)- and L(+)-isomers. The aim of this study was to investigate whether racemic LR solution (containing both isomers, dl-LR) differs from LR containing L-isomer only (L-LR).
METHODS: Blood from 20 volunteers was incubated for 30 minutes with lactated Ringer's solutions containing the DL- or L-form of lactate, Hank's balanced salt solution, normal saline, and ketone Ringer's (lactate replaced with ketone bodies). Neutrophil "oxidative burst" was measured using flow cytometry. Gene expression of 23 genes associated with leukocyte function was determined with cDNA array technique. The arraying procedure was repeated four times to obtain four sets of data.
RESULTS: Compared with the L-LR and ketone Ringer's, DL-LR causes an increased production of reactive oxygen species by neutrophils and affects expression of leukocyte genes known to be involved in inflammation, cell migration, and apoptosis.
CONCLUSION: Lactated Ringer's solution in commonly used formulation (racemic mixture, DL-LR) influences neutrophil function and leukocyte gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988652     DOI: 10.1097/00005373-200205000-00009

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  13 in total

1.  The Impact of Pre-Hospital Administration of Lactated Ringer's Solution versus Normal Saline in Patients with Traumatic Brain Injury.

Authors:  Susan E Rowell; Kelly A Fair; Ronald R Barbosa; Jennifer M Watters; Eileen M Bulger; John B Holcomb; Mitchell J Cohen; Mohammad H Rahbar; Erin E Fox; Martin A Schreiber
Journal:  J Neurotrauma       Date:  2016-02-25       Impact factor: 5.269

Review 2.  Combat casualty care research: from bench to the battlefield.

Authors:  Hasan B Alam; Elena Koustova; Peter Rhee
Journal:  World J Surg       Date:  2005       Impact factor: 3.352

Review 3.  [Estimation of substitution volume after burn trauma. Systematic review of published formulae].

Authors:  O Spelten; W A Wetsch; S Braunecker; H Genzwürker; J Hinkelbein
Journal:  Anaesthesist       Date:  2011-03-31       Impact factor: 1.041

4.  The acute immunological response to blood transfusion is influenced by polymicrobial sepsis.

Authors:  Dina C Nacionales; Alex G Cuenca; Ricardo Ungaro; Lori F Gentile; Dallas Joiner; Minoru Satoh; Joanne Lomas-Neira; Alfred Ayala; Azra Bihorac; Matthew J Delano; Darwin N Ang; Philip A Efron
Journal:  Shock       Date:  2012-12       Impact factor: 3.454

5.  A novel fluid resuscitation strategy modulates pulmonary transcription factor activation in a murine model of hemorrhagic shock.

Authors:  Todd W Costantini; Jessica Deree; J O Martins; James G Putnam; Tercio de Campos; Raul Coimbra
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 6.  Fluid resuscitation: past, present, and the future.

Authors:  Heena P Santry; Hasan B Alam
Journal:  Shock       Date:  2010-03       Impact factor: 3.454

7.  Prehospital lactated ringer's solution treatment and survival in out-of-hospital cardiac arrest: a prospective cohort analysis.

Authors:  Akihito Hagihara; Manabu Hasegawa; Takeru Abe; Yoshifumi Wakata; Takashi Nagata; Yoshihiro Nabeshima
Journal:  PLoS Med       Date:  2013-02-19       Impact factor: 11.069

8.  Fluid management in major burn injuries.

Authors:  Mehmet Haberal; A Ebru Sakallioglu Abali; Hamdi Karakayali
Journal:  Indian J Plast Surg       Date:  2010-09

9.  Resuscitation with hydroxyethyl starch 130/0.4 attenuates intestinal injury in a rabbit model of sepsis.

Authors:  Wei-Hua Lu; Xiao-Ju Jin; Xiao-Gan Jiang; Zhen Wang; Jing-Yi Wu; Guang-Gui Shen
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

Review 10.  Methods for improved hemorrhage control.

Authors:  John B Holcomb
Journal:  Crit Care       Date:  2004-06-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.